Elite Pharmaceuticals Inc (ELTP)

[IB_]

There you go with your diversion again because you CAN'T give an honest answer to the original question concerning this paragraph of the SEC filing:
"In June 2021, the Company entered into a development and license agreement with Mikah, pursuant to which Mikah will engage in the research, development, sales and licensing of generic pharmaceutical products. In addition, Mikah will collaborate to develop and commercialize generic products including formulation development, analytical method development, manufacturing, sales and marketing of generic products. Initially two generic products were identified for the parties to develop."

What will Mikah be doing to aid in this agreement? What does Mikah bring to the table? What will Mikah contribute to deserve anything from this arrangement?

You can reply with nonsense, but you can't give a truthful, intelligent answer,



IB_🤴🏻